3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, +16

Mayo Clinic Proceedings

Hematological MalignancyMedicineOutcomes DataHematologyMyeloid Neoplasia +8

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger

Natasha Szuber, Rangit Vallapureddy, Domenico Penna, +7

American Journal of Hematology

Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial

Naseema Gangat, Christian Marinaccio, Ronan Swords, +31

Clinical Cancer Research

Urinary Extracellular Vesicles of Podocyte Origin and Renal Injury in Preeclampsia

Sarwat Gilani, Ulrik Dolberg Anderson, Muthuvel Jayachandran, +13

Journal of the American Society of Nephrology

Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model

Rangit Vallapureddy, Mythri Mudireddy, Domenico Penna, +8

Blood Cancer Journal

Leukemic TransformationMixed-phenotype Acute LeukemiaImmunologyGenetic EpidemiologyPathology +21

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

Tucker Coston, Prateek Pophali, Rangit Vallapureddy, +13

American Journal of Hematology

Therapy related‐chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from <i>de novo</i> CMML

Mrinal M. Patnaik, Rangit Vallapureddy, Fevzi Yalniz, +7

American Journal of Hematology

Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases

Mrinal M. Patnaik, Ana Alfonso Piérola, Rangit Vallapureddy, +9

Leukemia

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaImmunologyHematology +6

3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, +16

Blood

A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone

Mrinal M. Patnaik, Rangit Vallapureddy, Terra L. Lasho, +7

Leukemia

Hematological MalignancyChronic Myelomonocytic LeukemiaMast Cell DisorderSystemic MastocytosisMalignant Blood Disorder +6